Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

69 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Chemotherapy and angiogenesis in advanced cancer: vascular endothelial growth factor (VEGF) decline as predictor of disease control during taxol therapy in metastatic breast cancer.
Lissoni P, Fugamalli E, Malugani F, Ardizzoia A, Secondino S, Tancini G, Gardani GS. Lissoni P, et al. Among authors: secondino s. Int J Biol Markers. 2000 Oct-Dec;15(4):308-11. doi: 10.1177/172460080001500405. Int J Biol Markers. 2000. PMID: 11192826 Free article. Clinical Trial.
Abnormally enhanced blood concentrations of vascular endothelial growth factor (VEGF) in metastatic cancer patients and their relation to circulating dendritic cells, IL-12 and endothelin-1.
Lissoni P, Malugani F, Bonfanti A, Bucovec R, Secondino S, Brivio F, Ferrari-Bravo A, Ferrante R, Vigoré L, Rovelli F, Mandalà M, Viviani S, Fumagalli L, Gardani GS. Lissoni P, et al. Among authors: secondino s. J Biol Regul Homeost Agents. 2001 Apr-Jun;15(2):140-4. J Biol Regul Homeost Agents. 2001. PMID: 11501971
An analysis of p53, BAX and vascular endothelial growth factor expression in node-positive rectal cancer. Relationships with tumour recurrence and event-free survival of patients treated with adjuvant chemoradiation.
Cascinu S, Graziano F, Catalano V, Staccioli MP, Rossi MC, Baldelli AM, Barni S, Brenna A, Secondino S, Muretto P, Catalano G. Cascinu S, et al. Among authors: secondino s. Br J Cancer. 2002 Mar 4;86(5):744-9. doi: 10.1038/sj.bjc.6600155. Br J Cancer. 2002. PMID: 11875737 Free PMC article.
Long-term survival in patients with metastatic breast cancer receiving intensified chemotherapy and stem cell rescue: data from the Italian registry.
Martino M, Ballestrero A, Zambelli A, Secondino S, Aieta M, Bengala C, Liberati AM, Zamagni C, Musso M, Aglietta M, Schiavo R, Castagna L, Rosti G, Bruno B, Pedrazzoli P. Martino M, et al. Among authors: secondino s. Bone Marrow Transplant. 2013 Mar;48(3):414-8. doi: 10.1038/bmt.2012.149. Epub 2012 Aug 6. Bone Marrow Transplant. 2013. PMID: 22863724
High dose chemotherapy with autologous hematopoietic stem cell support for solid tumors other than breast cancer in adults.
Pedrazzoli P, Ledermann JA, Lotz JP, Leyvraz S, Aglietta M, Rosti G, Champion KM, Secondino S, Selle F, Ketterer N, Grignani G, Siena S, Demirer T; European Group for Blood and Marrow Transplantation (EBMT) Solid Tumors Working Party. Pedrazzoli P, et al. Among authors: secondino s. Ann Oncol. 2006 Oct;17(10):1479-88. doi: 10.1093/annonc/mdl044. Epub 2006 Mar 17. Ann Oncol. 2006. PMID: 16547069 Free article. Review.
Adjuvant high-dose chemotherapy with autologous hematopoietic stem cell support for high-risk primary breast cancer: results from the Italian national registry.
Pedrazzoli P, Martinelli G, Gianni AM, Da Prada GA, Ballestrero A, Rosti G, Frassineti GL, Aieta M, Secondino S, Cinieri S, Fedele R, Bengala C, Bregni M, Grasso D, De Giorgi U, Lanza F, Castagna L, Bruno B, Martino M; of Gruppo Italiano per il Trapianto di Midollo Osseo, Cellule staminali emopoietiche e terapia cellulare (GITMO) – Sezione Tumori Solidi. Pedrazzoli P, et al. Among authors: secondino s. Biol Blood Marrow Transplant. 2014 Apr;20(4):501-6. doi: 10.1016/j.bbmt.2013.12.569. Epub 2013 Dec 27. Biol Blood Marrow Transplant. 2014. PMID: 24374214 Free article.
Long-lasting responses with chemotherapy followed by T-cell therapy in recurrent or metastatic EBV-related nasopharyngeal carcinoma.
Secondino S, Pedrazzoli P, Basso S, Bossi P, Bianco A, Imarisio I, Pagani A, De Cicco M, Muscianisi S, Casanova M, Morosi C, Bergamini C, Benazzo M, Cossu Rocca M, Perotti C, Baldanti F, Zecca M, Licitra LF, Comoli P. Secondino S, et al. Front Immunol. 2023 Jul 11;14:1208475. doi: 10.3389/fimmu.2023.1208475. eCollection 2023. Front Immunol. 2023. PMID: 37497213 Free PMC article.
69 results